Policy Related Researches

THE CANADIAN DRUG POLICY COALITION (CDPC)and other organizations prepare this document.

• Main Aim of this review to revive the law.

• Review of Policy of different countries.

1. Special individual licences to import and use medicinal cannabis, while maintaining overall prohibitions over the plant, but establishing exceptions to the law to ensure patients’ access to cannabis (e.g. in Poland).

2. Regulation of supply through the creation of a licence system granted to individuals or private entities according to the type of activity they engage in (production, manufacture, export, processing, research, transport or sale), within which the state can play various roles – from central control to mere arbitration through regulatory bodies (e.g. in Colombia or Peru).

3. Regulation of demand with mechanisms allowing legal access to medications or herbal cannabis preparations through: self-cultivation, cannabis clubs, postal order, sale in clinics or sale in pharmacies (e.g. in Uruguay for recreational, and by default, medicinal use).

4. The design and implementation of public policies that regulate access to certain products, in compliance with the regulatory system in place for medicines (e.g. in Germany